Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Vantive Corporation -- Ignore unavailable to you. Want to Upgrade?

To: Trader Dave who wrote (2511)	9/29/1998 10:36:00 AM
From: investorgal	Read Replies (2) \| Respond to of 3033

Trader Dave, Please help me to understand your reasoning. Having employee options that are repriced at $13+ would make this a more attractive takeover target in my book. Even if a 100% premium was paid that would only be a price of $11.25 (given today's plunge). Employee options are still worthless and the "poison pill" is meaningless. If management didn't want to sell out they would have repriced the options a 2nd time like Scopus and Informix did. At least then Scopus employees made some money and Informix employees have a chance to make some. With the current option price, why in the world would a Vantive employee stay? It looks like someone in the market knows something about the quarter that isn't public.